¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2022 ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2022-06-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2022 ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2022-06-26
±³À°ÀÏÀÚ : 2022-06-26
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2022 ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­ÁÂ
ÁÖÃÖ±â°ü : ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ
´ã´çÀÚ : ±è¼ö¿¬
¿¬¶ôó : 02-2040-7736  
À̸ÞÀÏ : colon@kams.or.kr      
±³À°Á¾·ù : ¿Ü°úÀÇÇб³À°
Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 70,000¿ø      
ºñ°í Æò»ý/Á¤È¸¿ø : 50,000¿ø ºñȸ¿ø : 70,000¿ø Àü°øÀÇ/±ºÀÇ°ü/°£È£»ç : 10,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ09:00~09:20 Colon adenoma: when to remove and how to remove  ±è¼º°­(¿ì¸®µéÇ׿ܰú) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ09:20~09:40 How to write colonoscopic finding: Meet the standard  ºÀÁØ¿ì(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ09:40~10:00 Post-polypectomy surveillance colonoscopy guideline  Á¤¼º¿±(´ëÇ׺´¿ø) 
Åä·Ð 06-26 ¿Â¶óÀΠ10:00~10:10 Q & A  () 
È޽Ġ06-26 ¿Â¶óÀΠ10:10~10:30 Coffe Break  () 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ10:30~10:50 Clinical practice guideline for UC:  ¹é¼¼Áø(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ10:50~11:10 Clinical practice guideline for Crohn's disease:  ÀÓ±âÀ±(¼­¿ï¼Ûµµº´¿ø) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ11:10~11:30 Medication for irritable bowel sydrome  ÀÌ°­¹®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ11:30~11:50 How to approach patients complaining of fecal incontinence  È«±¤´ë(°í·ÁÀÇ´ë) 
Åä·Ð 06-26 ¿Â¶óÀΠ11:50~12:00 Q & A  () 
½Ä»ç 06-26 ¿Â¶óÀΠ12:00~13:00 Lunch  () 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ13:00~13:15 CME and CVL  ³ë°æÅÂ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ13:15~13:30 TME and LLND  ¹Ú¼ö¿¬(°æºÏÀÇ´ë) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ13:30~13:45 Primary tumor resection in stage IV colorectal cancer  ¹ÚÀºÁ¤(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ13:45~14:00 Ç×¾ÏÄ¡·á guideline for stage IV colorectal cancer  ÀÌÀçÀÓ(°¡Å縯ÀÇ´ë) 
Åä·Ð 06-26 ¿Â¶óÀΠ14:00~14:10 Q & A  () 
È޽Ġ06-26 ¿Â¶óÀΠ14:10~14:30 Coffee Break  () 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ14:30~14:45 Conventional hemorrhoidectomy I -  Á¶µ¿È£(¼­¿ï¼Ûµµº´¿ø) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ14:45~15:00 Conventional hemorrhoidectomy II -  Á¤ÇüÁß(´ëÇ׺´¿ø) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ15:00~15:15 Stapled hemorrhoidectomy  ÀåÇÑÁ¤(¾çº´¿ø) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ15:15~15:30 Principles in drainage & fistula surgery  ±è»ó¿ì(±¸º´¿ø) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ15:30~15:45 Sphincter-saving procedures for complex fistula I  ±èÇü·¡(ºÎ»êÇ׿¿ø) 
È޽Ġ06-26 ¿Â¶óÀΠ15:45~16:00 Coffee Break  () 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ16:00~16:15 Transanal approach  Çö±âÈÆ(¼­¿ï¼Ûµµº´¿ø) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ16:15~16:30 Transabdominal approach with or without mesh  ½ÅÀç¿ø(´ëÇ׺´¿ø) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ16:30~16:45 Surgical management for pelvic multi-organ prolapse  °ûµ¿¹Î(±¸º´¿ø) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ16:45~17:00 Minimally invasive method in hernia surgery  ÃÖ¼ºÀÏ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-26 ¿Â¶óÀΠ17:00~17:15 Surgical approach for recurrent inguinal hernia  À̼º·Ä(´ã¼ÒÀ¯º´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2022 ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2022-06-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³âÁ¦ 17Â÷ °³¿øÀǸ¦ À§ÇÑ ³»°úÇÐ ¿¬¼ö°­Á : 2022-06-26
´ÙÀ½±Û 2022³â ´ëÇѼÒÈ­±âÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö°­Á : 2022-06-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20370 ¼­¿ï International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY2 : 2024-05-28 0 183 2024-04-12
20369 ¼­¿ï International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY 1 : 2024-05-27 0 173 2024-04-12
20368 ¼­¿ï Á¦ 51ȸ º¹ºÎÃÊÀ½ÆÄ ¹× ³»½Ã°æÃÊÀ½ÆÄ Áø´Ü ¿öÅ©¼ó : 2024-05-26 0 180 2024-04-09
20367 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À°: 2024-05-26 0 171 2024-04-09
20366 ±¤ÁÖ 2024³âµµ ´ëÇÑÅëÁõÇÐȸ Ãá°è ¿¬¼ö±³À° : 2024-05-26 0 164 2024-04-09
20365 ¼­¿ï ÀÌ´ë¼­¿ïº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-05-26 0 248 2024-04-09
20364 ¼­¿ï ´ëÇѾ๰¿µ¾çÀÇÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-05-26 0 200 2024-04-09
20363 ¼­¿ï 2024³â ´ëÇѼö¸éÇÐȸ Ãá°è±âº»±³À°°­Á : 2024-05-26 0 135 2024-04-09
20362 ±¤ÁÖ Á¦77Â÷ ´ëÇÑÅëÁõÇÐȸ Çмú´ëȸ : 2024-05-25 0 112 2024-04-09
20361 °­¿ø ´ëÇÑ´ç´¢º´ÇÐȸ °­¿øÁöȸ Á¦7ȸ ´ç´¢º´±³À°ÀÚ ¼¼¹Ì³ª : 2024-05-25 0 182 2024-04-09
20360 ¼­¿ï 2024³âµµ ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Adult ADHD ½ÉÆ÷Áö¿ò : 2024-05-24 0 154 2024-04-09
20359 ¼­¿ï ´ëÇѾฮÇÐȸ Frontiers in Epithelial Transport 2024(2ÀÏÂ÷) : 2024-05-24 0 90 2024-04-09
20358 ¼­¿ï Á¦29Â÷ ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ Çмú´ëȸ¿Í ¿¬¼ö±³À° (2ÀÏÂ÷) : 2024-05-24 0 126 2024-04-09
20357 ¼­¿ï »ï¼º¼­¿ïº´¿ø 2024³â Á¦3ȸ SMC Æó°íÇ÷¾Ð ½ÉÆ÷Áö¾ö: 2024-05-24 0 170 2024-04-09
20356 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚµÈ ÀÌ°ú Áúȯ : 2024-05-23 0 128 2024-04-09
51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷